FilingReader Intelligence
Alkem Laboratories profit jumps 21% in Q1 2025
August 12, 2025 at 08:09 AM UTC•By FilingReader AI
Alkem Laboratories reported consolidated profit of ₹6,679.1 million for the quarter ended June 30, 2025, up 21% from ₹5,502.4 million in the same period last year. Total consolidated income reached ₹35,076.3 million.
The pharmaceutical company acquired 100% stakes in Adroit Biomed Limited for ₹1,400 million and Bombay Ortho Industries Private Limited for ₹1,470 million during the quarter.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:ALKEM•Bombay Stock Exchange
News Alerts
Get instant email alerts when Alkem Laboratories publishes news
Free account required • Unsubscribe anytime